|
US2014087059A1
|
|
Pharmaceutical composition and process for montelukast tablets
|
|
US6350471B1
|
|
Tablet comprising a delayed release coating
|
|
US6368628B1
|
|
Sustained release pharmaceutical composition free of food effect
|
|
US6348469B1
|
|
Solid compositions containing glipizide and polyethylene oxide
|
|
US6338857B1
|
|
Sustained release carbamazepine pharmaceutical composition free of food effect and a method for alleviating food effect in drug release
|
|
CZ256099A3
|
|
Preparation based on metoprolol and process of its preparation
|
|
SK96599A3
|
|
Method for the preparation of solid metoprolol composition
|
|
US6096341A
|
|
Delayed release tablet of bupropion hydrochloride
|
|
US6033686A
|
|
Controlled release tablet of bupropion hydrochloride
|
|
EP0987020A1
|
|
Metoprolol composition and processes for manufacturing the same
|
|
WO9712581A2
|
|
Novel composition containing an acid-labile omeprazole and process for its preparation
|
|
RU2161481C2
|
|
Novel composition containing acid-nonstable omeprazole and method of its preparing
|
|
ZA9608020B
|
|
Novel composition containing an acid labile omeprazole and process for its preparation.
|
